Artikel: Ceftazidime-Avibactam as Osteomyelitis Therapy: A Miniseries and Review of the Literature.
Antibiotics (Basel, Switzerland)
2023 Band 12, Heft 8
Abstract: Bone and joint infections (BJIs) caused by multidrug-resistant gram-negative bacteria are becoming a concern due to limited therapeutic options. Although not approved for these indications, an ever-growing amount of evidence supports the efficacy and ... ...
Abstract | Bone and joint infections (BJIs) caused by multidrug-resistant gram-negative bacteria are becoming a concern due to limited therapeutic options. Although not approved for these indications, an ever-growing amount of evidence supports the efficacy and safety of ceftazidime-avibactam as a therapy for osteomyelitis and prosthetic joint infections. Here, we present three cases of difficult-to-treat resistant |
---|---|
Sprache | Englisch |
Erscheinungsdatum | 2023-08-17 |
Erscheinungsland | Switzerland |
Dokumenttyp | Case Reports |
ZDB-ID | 2681345-2 |
ISSN | 2079-6382 |
ISSN | 2079-6382 |
DOI | 10.3390/antibiotics12081328 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.